MARKET HARBOROUGH MED.CTR — All Prescriptions & Medications — Page 16
Practice Code: C82009 | MARKET HARBOROUGH, LE16 9BX
Showing results 751-800 of 866
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 16 | 800 | £152 | +416.8% ▲ | |
| Umeclidinium bromide | 15 | 15 | £392 | -75.7% ▼ |
| Lormetazepam | 15 | 450 | £148 | +27.4% ▲ |
| Agomelatine | 15 | 448 | £191 | -15.3% ▼ |
| Tetracycline | 15 | 632 | £476 | +220.8% ▲ |
| Metronidazole | 15 | 600 | £61 | +126.8% ▲ |
| Etonogestrel/ethinylestradiol | 15 | 57 | £555 | +184.3% ▲ |
| Magnesium citrate | 15 | 1,260 | £479 | +107.5% ▲ |
| Ready to serve preterm infant formula (0913111) | 15 | 270.0K | £3.1K | +70.9% ▲ |
| Lidocaine | 15 | 840 | £91 | +217.0% ▲ |
| 15 | 264 | £639 | -54.0% ▼ | |
| 15 | 97 | £1.0K | +71.8% ▲ | |
| 15 | 60 | £729 | +229.7% ▲ | |
| Isosorbide dinitrate | 14 | 812 | £239 | -22.1% ▼ |
| Ciprofibrate | 14 | 392 | £981 | +4.8% ▲ |
| Sodium oxybate | 14 | 7,560 | £15.1K | +31.4% ▲ |
| Disulfiram | 14 | 392 | £1.3K | -5.5% ▼ |
| Buprenorphine hydrochloride | 14 | 392 | £81 | -97.8% ▼ |
| Megestrol acetate | 14 | 490 | £417 | +103.9% ▲ |
| Magnesium glycerophosphate | 14 | 1,656 | £1.1K | +1.9% vs avg |
| Sodium chloride | 14 | 44 | £571 | +111.5% ▲ |
| 14 | 370 | £915 | -31.7% ▼ | |
| 14 | 1,360 | £2.4K | +61.4% ▲ | |
| Misoprostol | 13 | 364 | £59 | +34.9% ▲ |
| Chlortalidone | 13 | 182 | £334 | +31.8% ▲ |
| Glycopyrronium bromide | 13 | 390 | £340 | -65.1% ▼ |
| Ketotifen fumarate | 13 | 780 | £180 | +49.4% ▲ |
| Trimipramine maleate | 13 | 364 | £2.7K | -18.4% ▼ |
| Ethosuximide | 13 | 1,456 | £3.9K | -11.9% ▼ |
| Alogliptin/metformin | 13 | 728 | £329 | -68.8% ▼ |
| Ins degludec/liraglutide | 13 | 78 | £2.5K | -19.1% ▼ |
| Raloxifene hydrochloride | 13 | 364 | £57 | -12.0% ▼ |
| Sodium clodronate | 13 | 780 | £1.8K | +20.4% ▲ |
| Fesoterodine fumarate | 13 | 364 | £319 | -67.0% ▼ |
| Sodium zirconium cyclosilicate | 13 | 840 | £4.5K | +48.0% ▲ |
| RtS extensively hydrolysed formula, high energy (0913103) | 13 | 364.0K | £9.2K | +127.1% ▲ |
| Tube feed 1.5 kcal/ml with fibre (0914021) | 13 | 175.0K | £4.4K | +13.5% ▲ |
| Levofloxacin | 13 | 575 | £364 | +206.3% ▲ |
| Hydrocortisone acetate | 13 | 130 | £411 | +96.7% ▲ |
| 13 | 102 | £187 | +106.0% ▲ | |
| 13 | 13 | £110 | +30.0% ▲ | |
| 13 | 265 | £179 | +106.2% ▲ | |
| 13 | 510 | £804 | +62.7% ▲ | |
| 13 | 650 | £98 | +255.1% ▲ | |
| 13 | 1,050 | £3.4K | +19.5% ▲ | |
| Dicycloverine hydrochloride | 12 | 1,008 | £1.1K | +1.4% vs avg |
| Propafenone hydrochloride | 12 | 720 | £107 | +10.8% ▲ |
| Celiprolol hydrochloride | 12 | 336 | £203 | -9.3% ▼ |
| Prazosin hydrochloride | 12 | 720 | £29 | -28.7% ▼ |
| Paliperidone | 12 | 12 | £11.0K | -21.1% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.